These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18071926)

  • 21. Direct and indirect effects of perceived social support on health-related quality of life in persons living with HIV/AIDS.
    Bekele T; Rourke SB; Tucker R; Greene S; Sobota M; Koornstra J; Monette L; Rueda S; Bacon J; Watson J; Hwang SW; Dunn J; Guenter D;
    AIDS Care; 2013; 25(3):337-46. PubMed ID: 22774876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies.
    Wu AW; Hanson KA; Harding G; Haider S; Tawadrous M; Khachatryan A; Pashos CL; Simpson KN
    Health Qual Life Outcomes; 2013 Mar; 11():42. PubMed ID: 23497257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in health-related quality of life in patients with HIV/AIDS.
    Mrus JM; Williams PL; Tsevat J; Cohn SE; Wu AW
    Qual Life Res; 2005 Mar; 14(2):479-91. PubMed ID: 15892437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
    Olsen IC; Kvien TK; Uhlig T
    Osteoarthritis Cartilage; 2012 Aug; 20(8):822-8. PubMed ID: 22441031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability and validity of the Chinese version of the Medical Outcomes Study HIV Health Survey (MOS-HIV) in people living with HIV/AIDS (PLWHA) in China.
    Liu J; Zhu Y; Qu B
    PLoS One; 2018; 13(7):e0201177. PubMed ID: 30044881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes and Consequences of Missing Health-Related Quality of Life Assessments in Patients Who Undergo Mechanical Circulatory Support Implantation: Insights From INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Grady KL; Jones PG; Cristian-Andrei A; Naftel DC; Myers S; Dew MA; Idrissi K; Weidner G; Wissman SA; Kirklin JK; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003268. PubMed ID: 29246883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An application of a pattern-mixture model with multiple imputation for the analysis of longitudinal trials with protocol deviations.
    Iddrisu AK; Gumedze F
    BMC Med Res Methodol; 2019 Jan; 19(1):10. PubMed ID: 30626328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
    Revicki DA; Moyle G; Stellbrink HJ; Barker C
    AIDS; 1999 May; 13(7):851-8. PubMed ID: 10357386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
    Dimitrakopoulou V; Efthimiou O; Leucht S; Salanti G
    Stat Med; 2015 Feb; 34(5):742-52. PubMed ID: 25492741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes and determinants of health-related quality of life among people newly diagnosed with HIV in China: a 1-year follow-up study.
    Huang Y; Luo D; Chen X; Zhang D; Wang M; Qiu Y; Liu Y; Peng B; Niu L; Xiao S
    Qual Life Res; 2019 Jan; 28(1):35-46. PubMed ID: 30206817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.
    Hedden SL; Woolson RF; Carter RE; Palesch Y; Upadhyaya HP; Malcolm RJ
    J Subst Abuse Treat; 2009 Jul; 37(1):54-63. PubMed ID: 19008067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How should we deal with missing data in clinical trials involving Alzheimer's disease patients?
    Coley N; Gardette V; Cantet C; Gillette-Guyonnet S; Nourhashemi F; Vellas B; Andrieu S
    Curr Alzheimer Res; 2011 Jun; 8(4):421-33. PubMed ID: 21244348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV Validation Group.
    Badia X; Podzamczer D; Casado A; López-Lavid C; García M
    AIDS; 2000 Jul; 14(10):1439-47. PubMed ID: 10930160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients.
    Weinfurt KP; Willke RJ; Glick HA; Freimuth WW; Schulman KA
    Med Care; 2000 Apr; 38(4):404-10. PubMed ID: 10752972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missing data in alcohol clinical trials: a comparison of methods.
    Hallgren KA; Witkiewitz K
    Alcohol Clin Exp Res; 2013 Dec; 37(12):2152-60. PubMed ID: 23889334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir.
    Cuffe R; Barnett C; Granier C; Machida M; Wang C; Roger J
    HIV Clin Trials; 2015 Oct; 16(5):170-7. PubMed ID: 26365498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus.
    Chan KS; Revicki DA
    Eval Health Prof; 1998 Jun; 21(2):265-81. PubMed ID: 10183347
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.